sarepta duchenne muscular dystrophy

  • Duvyzatâ„¢ (givinostat) | An FDA-Approved Therapy

    https://www.duvyzat.com
    AdExplore Duvyzatâ„¢ (givinostat), an FDA-approved treatment, and see if it is right for you. Duvyzatâ„¢ offers several patient support programs through ITF ARC. Learn more here.

    Join a Webinar · Helpful Resources · ITF ARC Support · About DUVYZATâ„¢

Biotechnology company in Cambridge, United States
Suggest an edit · Your business? Claim now

Add more information

Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare …

Frequently asked questions

Q:
What is a rare condition?
A:
In the United States, any disorder that affects fewer than 200,000 people is considered rare. Men, women, children, and the elderly can be affected....
Data from: BusinessWebsite
Oops! Something went wrong, Please try again after a few minutes